Al-Ibraheem A, Scott AM, Abdlkadir AS, Vrachimis A, Lamoureux F, Trujillo PB, et al. Consensus Nomenclature for Radionuclide Therapy: Initial Recommendations from Nuclear Medicine Global Initiative. J Nucl Med Off Publ Soc Nucl Med J Nucl Med. 2025;66:757–63.

CAS  Google Scholar 

Pomykala KL, Hadaschik BA, Sartor O, Gillessen S, Sweeney CJ, Maughan T, et al. Next generation radiotheranostics promoting precision medicine. Ann Oncol Elsevier. 2023;34:507–19.

Article  CAS  Google Scholar 

Jadvar H, Chen X, Cai W, Mahmood U. Radiotheranostics in Cancer Diagnosis and Management. Radiological Soc North Am. 2018;286:388–400. https://doi.org/101148/radiol2017170346.

Google Scholar 

Baum RP, Kulkarni HR. THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience. Theranostics Ivyspring Int Publisher. 2012;2:437–47.

Article  CAS  Google Scholar 

Fahey FH, Grant FD, Thrall JH. Saul Hertz, MD, and the birth of radionuclide therapy. EJNMMI Phys Springer Int Publishing. 2017;4:1–7.

Google Scholar 

SEIDLIN SM, MARINELLI LD, OSHRY E. RADIOACTIVE IODINE THERAPY. Effect on Functioning Metastases of Adenocarcinoma of the Thyroid. J Am Med Assoc Am Med Association. 1946;132:838–47.

Article  CAS  Google Scholar 

Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, et al. Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors. N Engl J Med New Engl J Med (NEJM/MMS). 2017;376:125–35.

Article  CAS  Google Scholar 

Hofman MS, Violet J, Hicks RJ, Ferdinandus J, Ping Thang S, Akhurst T, et al. [ 177 Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study. Lancet Oncol Lancet Publishing Group. 2018;19:825–33.

Article  CAS  Google Scholar 

Lange R, Ter Heine R, Decristoforo C, Peñuelas I, Elsinga PH, Van Der Westerlaken MML, et al. Untangling the web of European regulations for the preparation of unlicensed radiopharmaceuticals: A concise overview and practical guidance for a risk-based approach. Nucl Med Commun Lippincott Williams Wilkins. 2015;36:414–22.

Article  CAS  Google Scholar 

Radiotheranostics Market Size, Share &, Growth R. 2030. [Internet]. [cited 2025 Dec 1]. https://www.grandviewresearch.com/industry-analysis/radiotheranostics-market-report. Accessed 1 Dec 2025.

Part Index | NRC.gov. https://www.nrc.gov/reading-rm/doc-collections/cfr/part035/index.html

Gillings N, Hjelstuen O, Ballinger J, Behe M, Decristoforo C, Elsinga P, et al. Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals. EJNMMI Radiopharm Chem Springer Sci Bus Media Deutschland GmbH. 2021;6:1–22. edicines (ARGPM) | Therapeutic Goods Administration (TGA). https://www.tga.gov.au/resources/resource/reference-material/australian-regulatory-guidelines-prescription-medicines-argpm.

Google Scholar 

Bakker RC, de Roos R, Ververs FFT, Lam MGEH, van der Lee MK, Zonnenberg BA, et al. Blood and urine analyses after radioembolization of liver malignancies with [166Ho]Ho-acetylacetonate-poly(l-lactic acid) microspheres. Nucl Med Biol Elsevier. 2019;71:11–8.

Article  CAS  Google Scholar 

View of Radiotheranostics in Oncology. https://www.ijtos.com/index.php/journal/article/view/34/33

Proceedings National Regulatory. Authorities with Competence in the Safety of Radiation Sources and the Security of Radioactive Materials International Atomic Energy Agency.

Overview of Device Regulation | FDA. https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatory-assistance/overview-device-regulation

Hattangadi JA, O’Reilly JT, Recht A. US Food and Drug Administration Regulation of Medical Devices and Radiation Oncology: Can Reform Improve Safety? J Oncol Pract. 2011;8:53.

Article  PubMed  PubMed Central  Google Scholar 

Perera M, Morris MJ. From Concept to Regulatory Drug Approval: Lessons for Theranostics. J Nucl Med. 2022;63:1793–801.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Radiopharmaceuticals regulatory considerations – EANM. https://eanm.org/eu-global-affairs/policy/radiopharmaceuticals-regulatory-considerations/

Clinical trials - European Commission. https://health.ec.europa.eu/medicinal-products/clinical-trials_en

Regulations and Approval/Certification of Medical Devices | Pharmaceuticals. and Medical Devices Agency. https://www.pmda.go.jp/english/review-services/reviews/0004.html

Zhang W, Zhang L, Zhao Y, Chen Y. Avid 68Ga-PSMA uptake in accessory submandibular salivary gland. Clin Nucl Med. Lippincott Williams and Wilkins; 2019;44:591–3.

Medical devices | Australian Government Department of Health and, Care A. https://www.health.gov.au/topics/medical-devices

Francis RJ, Bailey DL, Hofman MS, Scott AM. The Australasian Radiopharmaceutical Trials Network: Clinical Trials, Evidence, and Opportunity. J Nucl Med Soc Nuclear Med Inc. 2021;62:755–755.

Google Scholar 

Regulatory. Requirements and Guidelines for new Nuclear Medicine Facility. www.aerb.gov.in.

Consenting process in radiation facilities | AERB - Atomic. Energy Regulatory Board. https://aerb.gov.in/english/consenting-process-in-radiation-facilities

clinical Trials. https://cdsco.gov.in/opencms/opencms/en/Clinical-Trial/clinical-trials/

Japanese Medical Device Regulatory Approval Process. | Emergo by UL. https://www.emergobyul.com/resources/japanese-regulatory-approval-process-medical-devices

Pacific JAPANA, Baker McKenzie J, Kengo Nishigaki J, Tateishi R. Clinical Trials Handbook.

Introducing. Innovative MDs.

HSA | Medical devices. https://www.hsa.gov.sg/medical-devices

HSA Revised Guidance on Medical Device Product Registration. Specific Aspects | HSA. https://www.regdesk.co/hsa-revised-guidance-on-medical-device-product-registration-specific-aspects/

Pacific Singaporea. clinical trials handbook.

Chen A, Zhang J. Medical Device Regulations in China Meeting NMPA requirements. 2024.

A Bird’s Eye View of the Nuclear Medicine. and Radiopharmaceuticals Market in China. https://veranex.com/2024/01/12/a-birds-eye-view-of-the-nuclear-medicine/

China Introduces Revised Medical Devices Supervision and Administration. Regulations | ChemLinked. https://baipharm.chemlinked.com/news/china-introduces-revised-medical-devices-supervision-and-administration-regulations

Multijurisdictional RA. Testing Requirements. 2021.

Commission I of M (US). C for R and E of the MUP of the NR. In: Gottfried K-LD, Penn G, editors. Regulation and Radiation Medicine. National Academies Press (US); 1996. https://www.ncbi.nlm.nih.gov/books/NBK232722/.

Bodei L, Herrmann K, Schöder H, Scott AM, Lewis JS. Radiotheranostics in oncology: current challenges and emerging opportunities. Nat Rev Clin Oncol. 2022;19:534.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Review 9 M Re-examination Period: (Exclusivity Period) 8-10years. 2021; www.iqvia.co.jp

Home | ARPANSA [Internet]. [cited 2024 Dec 2]. https://www.arpansa.gov.au/. Accessed 2 Dec 2024.

Fillimi [Internet]. [cited 2025 Dec 5]. https://akbpm.gov.al/. Accessed 5 Dec 2025.

Bundesamt für Sicherheit im Gesundheitswesen [Internet]. BASG. [cited 2025 Dec 5]. https://www.basg.gv.at/. Accessed 5 Dec 2025.

Medical devices | European Medicines Agency (EMA). https://www.ema.europa.eu/en/human-regulatory-overview/medical-devices

National Health Regulatory Authority Bahrain [Internet]. [cited 2025 Dec 5]. https://www.nhra.bh/. Accessed 5 Dec 2025.

Bangladesh Atomic Energy Commission-Government of the People’. s Republic of Bangladesh [Internet]. [cited 2025 Dec 5]. https://baec.gov.bd/. Accessed 5 Dec 2025.

Department of Drug Administration-Government of the People’. s Republic of Bangladesh [Internet]. [cited 2025 Dec 5]. https://dgda.gov.bd/. Accessed 5 Dec 2025.

FANC - Federal Agency for Nuclear Control. | Protecting Together [Internet]. [cited 2025 Dec 5]. https://fanc.fgov.be/nl. Accessed 5 Dec 2025.

FAMHP | Your medicine. and health products [Internet]. [cited 2025 Dec 5]. https://www.famhp.be/en. Accessed 5 Dec 2025.

Agency for Medicines Product and Medical. Devices of Bosnia and Herzegovina [Internet]. [cited 2025 Dec 5]. https://almbih.gov.ba/en/agencija-za-lijekove-i-medicinska-sredstva-bosne-i-hercegovine-eng/. Accessed 5 Dec 2025.

BDA - Official website of the Bulgarian. Medicines Agency under the Ministry of Health of the Republic of Bulgaria [Internet]. [cited 2025 Dec 5]. https://www.bda.bg/bg/. Accessed 5 Dec 2025.

Instituto de Salud. Pública de Chile [Internet]. [cited 2025 Dec 5]. https://www.ispch.cl/. Accessed 5 Dec 2025.

Comisión Chilena de. Energía Nuclear [Internet]. [cited 2025 Dec 5]. https://www.cchen.cl/. Accessed 5 Dec 2025.

Canada H. Medical devices [Internet]. 2004 [cited 2025 Dec 5]. https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-devices.html. Accessed 5 Dec 2025.

HALMED. HALMED - Agencija za lijekove i medicinske proizvode [Internet]. HALMED - Agencija Za Lijek. Med. Proizv. [cited 2025 Dec 5]. https://www.halmed.hr/. Accessed 5 Dec 2025.

Úvodní stránka -. Oficiální stránky Státního ústavu pro kontrolu léčiv [Internet]. SÚKL. [cited 2025 Dec 5]. https://sukl.gov.cz/. Accessed 5 Dec 2025.

Úvod -. SÚJB [Internet]. [cited 2025 Dec 5]. https://sujb.gov.cz/. Accessed 5 Dec 2025.

Lægemiddelstyrelsen [Internet]. Lægemiddelstyrelsen. [cited 2025 Dec 5]. https://laegemiddelstyrelsen.dk/da/. Accessed 5 Dec 2025.

Homepage - ENRRA [Internet]. [cited 2025 Dec 5]. https://enrra.org/. Accessed 5 Dec 2025.

Avaleht | Ravimiamet [Internet]. [cited 2025 Dec 5]. https://ravimiamet.ee/. Accessed 5 Dec 2025.

Etusivu [Internet]. Fimea. [cited 2025 Dec 5]. https://fimea.fi/etusivu. Accessed 5 Dec 2025.

Home | Radiation and Nuclear Safety Authority STUK [Internet]. [cited 2025 Dec 5]. https://stuk.fi/etusivu. Accessed 5 Dec 2025.

Accueil [Internet]. ANSM. [cited 2025 Dec 5]. https://ansm.sante.fr/. Accessed 5 Dec 2025.

BfArM - Startseite. [Internet]. [cited 2025 Dec 5]. https://www.bfarm.de/DE/Home/_node.html. Accessed 5 Dec 2025.

Hellenic Atomic Energy Commission [Internet]. [cited 2025 Dec 5]. https://www.eeae.gr/. Accessed 5 Dec 2025.

Országos Gyógyszerészeti és. Élelmezés-egészségügyi Intézet [Internet]. Orsz. Gyógyszerészeti És Élelmez.-Egészségügyi Intéz. [cited 2025 Dec 5]. https://ogyei.gov.hu/nyitooldal. Accessed 5 Dec 2025.

Országos Atomenergia Hivatal. [Internet]. [cited 2025 Dec 5]. https://www.haea.hu/web/v3/OAHPortal.nsf/web?OpenAgent. Accessed 5 Dec 2025.

Brandoctors. Beranda | Badan Pengawas Obat dan Makanan [Internet]. [cited 2025 Dec 5]. https://www.pom.go.id. Accessed 5 Dec 2025.

Agenzia Italiana del Farmaco [Internet]. [cited 2025 Dec 5]. https://www.aifa.gov.it/. Accessed 5 Dec 2025.

KNRA – Kenya Nuclear Regulatory Authority. [Internet]. [cited 2025 Dec 5]. https://knra.co.ke/. Accessed 5 Dec 2025.

Pautan Pintas Portal Rasmi [Internet]. [cited 2025 Dec 5]. https://www.mda.gov.my/. Accessed 5 Dec 2025.

Home - Food and Drug Administration [Internet]. 2021 [cited 2025 Dec 5]. https://www.fda.gov.ph/. Accessed 5 Dec 2025.

| الموقع الإلكتروني. الرسمي للهيئة العامة للغذاء والدواء [Internet]. [cited 2025 Dec 5]. https://www.sfda.gov.sa/. Accessed 5 Dec 2025.

SAHPRA - South African. Health Products Regulatory Authority [Internet]. SAHPRA. [cited 2025 Dec 5]. https://www.sahpra.org.za/. Accessed 5 Dec 2025.

Medicines and Healthcare products Regulatory Agency [Internet]. GOV.UK. 2025 [cited 2025 Dec 5]. https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency. Accessed 5 Dec 2025.

Brightwire.net. Home [Internet]. Off. Nucl. Regul. https://www.brightwire.net; 2025 [cited 2025 Dec 5]. https://www.onr.org.uk/. Accessed 5 Dec 2025.

Australian Regulatory Guidelines for Prescription Medicines (ARGPM) | Therapeutic Goods Administration (TGA). https://www.tga.gov.au/resources/resource/reference-material/australian-regulatory-guidelines-prescription-medicines-argpm

Guidance for Industry and Researchers the Radioactive Drug Research Committee: Human Research Without An Investigational New Drug Application. 2010; https://www.reginfo.gov

Regulations. Good Clinical Practice and Clinical Trials | FDA. https://www.fda.gov/science-research/clinical-trials-and-human-subject-protection/regulations-good-clinical-practice-and-clinical-trials

Administration D. Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics Guidance for Industry. 2018;https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/default.htmand/orhttps://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/default.htm

Radiation protection legislation - European Commission. https://energy.ec.europa.eu/topics/nuclear-energy/radiation-protection/radiation-protection-legislation_en

Directive – 2013/59 - EN - EUR-Lex. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32013L0059

Medical Technology Regulations. - MedTech Europe. https://www.medtecheurope.org/new-medical-technology-regulations/

Van Norman GA, Drugs. Comparison of European and U.S. Approval Processes. JACC Basic Transl Sci Elsevier Inc. 2016;1:399–399.

Google Scholar 

www.topra.org/CPDsupplements i CPD with Regulatory Rapporteur. 2019; https://eur-lex.europa.eu/

Clinical Trials Regulation | European Medicines Agency (EMA). https://www.ema.europa.eu/en/human-regulatory-overview/research-development/clinical-trials-human-medicines/clinical-trials-regulation

⁣Medical device approv